MNWIX
Price
$13.35
Change
-$0.05 (-0.37%)
Updated
Dec 12 closing price
Net Assets
37.96M
MNWRX
Price
$12.59
Change
-$0.05 (-0.40%)
Updated
Dec 12 closing price
Net Assets
37.96M
Interact to see
Advertisement

MNWIX vs MNWRX

Header iconMNWIX vs MNWRX Comparison
Open Charts MNWIX vs MNWRXBanner chart's image
MFS Managed Wealth I
Price$13.35
Change-$0.05 (-0.37%)
VolumeN/A
Net Assets37.96M
MFS Managed Wealth R1
Price$12.59
Change-$0.05 (-0.40%)
VolumeN/A
Net Assets37.96M
MNWIX vs MNWRX Comparison Chart in %
View a ticker or compare two or three
VS
MNWIX vs. MNWRX commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNWIX is a Hold and MNWRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MNWIX (38M) and MNWRX (38M) have equal amount of cash in the bank . MNWIX pays higher dividends than MNWRX: MNWIX (1.06) vs MNWRX (0.27). MNWIX was incepted earlier than MNWRX: MNWIX (11 years) vs MNWRX (11 years). MNWRX (2.66) is less costly to investors than MNWIX (1.66). MNWIX (11.00) and MNWRX (11.00) have comparable annual turnover. MNWIX (0) and MNWRX (0) have matching initial minimum investment requirements. MNWIX annual gain was more profitable for investors over the last year : 6.28 vs. MNWRX (5.19). MNWIX return over 5 years is better than : 19.30 vs. MNWRX (14.20).
MNWIXMNWRXMNWIX / MNWRX
Total Expense Ratio1.142.1453%
Annual Report Gross Expense Ratio1.662.6662%
Fund Existence11 years11 years-
Gain YTD7.5446.487116%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets38M38M100%
Annual Yield % from dividends1.060.27396%
Returns for 1 year6.285.19121%
Returns for 3 years19.5816.83116%
Returns for 5 years19.3014.20136%
Returns for 10 years37.3126.88139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNTX1.540.05
+3.36%
Rein Therapeutics Inc
OPFI10.980.24
+2.23%
OppFi
DBX27.620.42
+1.54%
Dropbox
MRK99.011.39
+1.42%
Merck & Co
AMLX13.07-0.16
-1.21%
Amylyx Pharmaceuticals